A study from the Austrian Stroke Unit Registry including 890 minor stroke patients (of 445 in t‐PA group) suggested IV t‐PA treatment might be beneficial for patients with mild neurological deficits and the numbers need to treat 8–14.21 This evidence concerns the gene PLAT and Stroke.